Leoni Mollie
Chief Medical Officer
Leoni Mollie has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Leoni Mollie is listed as Chief Medical Officer at Kura Oncology, Inc. Inside the rolling window, Leoni Mollie reported no open-market purchases and 4 open-market sales totaling $1.2M in KURA. The largest disclosed transaction in the window is a sale of 84,929 KURA shares on Jun 18, 2026, worth $834K.
Companies traded
Other insiders at KURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Leoni Mollie made?
Leoni Mollie has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Leoni Mollie trade?
Leoni Mollie has filed SEC Form 4 disclosures for 1 company, including KURA.
When was Leoni Mollie's most recent SEC Form 4 filing?
Leoni Mollie's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Leoni Mollie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Leoni Mollie is listed as Chief Medical Officer.
What is Leoni Mollie's total buy and sell value in the current window?
Inside the rolling retention window, Leoni Mollie bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Leoni Mollie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 84,929 KURA shares on 2026-06-18, worth $834K, per SEC Form 4 filings.